Mint Pharmaceuticals Private Limited
About Mint Pharmaceuticals Private Limited
Data last updated:
Mint Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 June 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51397TN2007PTC063756. Its GSTIN is 33AAFCM0871P1Z6 (Tamil Nadu).
The company has an authorised share capital of ₹32 Lakh and a paid-up capital of ₹30.79 Lakh. It is led by directors including Kannan Umamaheshwari and Chitra Sathappan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plotno132 Natesan Nagar Third Main Road Virugambakkam, Chennai, Tamil Nadu, India – 600092.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.67 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹3.7 Lakh (net margin 0.8%) and EBITDA of ₹16.33 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 7% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlotno132 Natesan Nagar Third Main Road Virugambakkam, Chennai, Tamil Nadu, India – 600092
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mint Pharmaceuticals Private Limited
The main business activity of Mint Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mint Pharmaceuticals Private Limited FY 2024 filings available
Mint Pharmaceuticals Private Limited reported revenue of ₹4.67 Cr (down 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Mint Pharmaceuticals Private Limited
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mint Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.33 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.7 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mint Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mint Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mint Pharmaceuticals Private Limited
Mint Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aarkem Healthcare Private Limited | ₹4.68 Cr (FY 2025) | •••• | •••• | 228.0% | •••• | Tijara, Rajasthan, India |
| Bis Marck Pharmaceuticals Private Limited | ₹4.68 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Rajkot, Gujarat, India |
| Dell Win Pharmaceuticals Private Limited | ₹4.68 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Lakshmi Narsimha Diagnostics & Healthcare Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Batra Businesses Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Jaipur, Rajasthan, India |
| Mint Pharmaceuticals Private Limited this company | ₹4.67 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
| Wallet Pharma Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 83.0% | •••• | Hyderabad, Telangana, India |
| Kale Pharma Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Pune, Maharashtra, India |
| Amar Pharmaceuticals and Labs (India) Private Limited | ₹4.67 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Kanpur, Uttar Pradesh, India |
| Dua Health Care Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Exgen Care Private Limited | ₹4.67 Cr (FY 2024) | •••• | •••• | 71.0% | •••• | Noida, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Mint Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mint Pharmaceuticals Private Limited
Mint Pharmaceuticals Private Limited is audited by AR ANNAMALAI & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AR ANNAMALAI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mint Pharmaceuticals Private Limited
Mint Pharmaceuticals has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kannan Umamaheshwari | Director | 03 Jan 2024 | 2 Years 9 Months | Current |
| Chitra Sathappan | Director | 04 Jun 2007 | 19 Years 4 Months | Current |
| Ramasamy Sivaprakasam | Director | 04 Jun 2007 | 19 Years 4 Months | Current |
| Sethuraman Sathappan | Director | 04 Jun 2007 | 19 Years 4 Months | Current |
| Muthu Pazaniappan Umayal | Director | 04 Jun 2007 | 19 Years 4 Months | Current |
Ownership and Shareholding of Mint Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mint Pharmaceuticals Private Limited
Mint Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Mint Pharmaceuticals Private Limited
Mint Pharmaceuticals Private Limited has 1 court case on record: 1 where it is another party. All case is disposed. Status as checked on 29 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Criminal miscellaneous application | Company is another party | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Mint Pharmaceuticals Private Limited
Mint Pharmaceuticals Private Limited has a workforce of 26 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mint Pharmaceuticals Private Limited
Mint Pharmaceuticals Private Limited has 9 board changes on record since 2007: 5 appointments and 4 cessations. The latest: Kannan Umamaheshwari ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Mint Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mint Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mint Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mint Pharmaceuticals Private Limited
Mint Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCM0871P1Z6 | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mint Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mint Pharmaceuticals Private Limited
Mint Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 June 2007 (19+ years old) and is registered under CIN U51397TN2007PTC063756.
Mint Pharmaceuticals reported revenue of ₹4.67 Cr for FY 2024 (down 5% YoY).
Mint Pharmaceuticals has 5 current directors:
- Kannan Umamaheshwari - Director
- Chitra Sathappan - Director
- Ramasamy Sivaprakasam - Director
- Sethuraman Sathappan - Director
- Muthu Pazaniappan Umayal - Director
Mint Pharmaceuticals reported a net profit of ₹3.7 Lakh (net margin 0.8%) and EBITDA of ₹16.33 Lakh (EBITDA margin 3.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mint Pharmaceuticals is 15% over three years and 7% over five years. In the latest year (FY 2024) revenue fell 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mint Pharmaceuticals is 33AAFCM0871P1Z6, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Mint Pharmaceuticals is U51397TN2007PTC063756. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mint Pharmaceuticals has 1 court case on record.
Mint Pharmaceuticals was incorporated on 04 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Mint Pharmaceuticals by revenue are Aarkem Healthcare Private Limited, Bis Marck Pharmaceuticals Private Limited, Dell Win Pharmaceuticals Private Limited, Lakshmi Narsimha Diagnostics & Healthcare Private Limited, Batra Businesses Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Kannan Umamaheshwari ceased to be Additional Director on 29 Sep 2024. Kannan Umamaheshwari was appointed as Director on 03 Jan 2024. Jayamkondan Chinna Meena ceased to be Director on 19 Aug 2022. Mint Pharmaceuticals has 9 board changes on record in total.